Streetbeat News

Stock Prices

CARG

CarGurus projects its Q1 2024 adjusted EPS to be between $0.24 and $0.29, below the estimated $0.31. The company also forecasts revenue to range from $201M to $221M, which is lower than the expected $235.698M.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:27 pm

STRL

Sterling Infrastructure's shares saw an increase following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:26 pm

CARG

CarGurus shares are trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:26 pm

FGEN

FibroGen (NASDAQ:FGEN) reported Q4 earnings with a -36.0% miss on estimated EPS, recording an EPS of $-0.57 against an estimate of $-0.42. Revenue decreased by $7.23 million from the same period last year. Despite beating EPS estimates in Q3 2023, the share price dropped by 1.0% the following day.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 9:25 pm

HLIO

Helios Technologies (NYSE:HLIO) reported Q4 earnings with a 41.0% beat on EPS estimates, posting $0.38 versus the expected $0.27. However, revenue decreased by $2.60 million compared to the same period last year. The company had previously missed EPS estimates last quarter, which led to a 17.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 9:25 pm

SIBN

SI-BONE (NASDAQ:SIBN) reported Q4 earnings, beating estimated earnings by 4.0% with an EPS of $-0.27 versus an estimate of $-0.28. Revenue increased by $6.91 million from the same period last year. Despite beating EPS estimates in the past, such as last quarter's beat by $0.09, the share price dropped by 2.0% the following day.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 9:25 pm

HIMS

Hims & Hers Health's shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided optimistic future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:25 pm

SIBN

SI-BONE (NASDAQ:SIBN) reported Q4 2023 earnings with a GAAP EPS of $(0.27), missing the $(0.26) estimate by 3.85%. However, their sales of $38.86M exceeded the $37.61M estimate by 3.31%, marking a 21.61% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:24 pm

TMDX

TransMedics shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided strong future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:24 pm

AIN

Albany Intl (AIN) reported Q4 2023 adjusted EPS of $1.22, surpassing the $0.82 estimate, with sales of $323.60M also beating the $298.26M estimate. This represents a 20.39% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 9:23 pm